Re Collaboration Agreement

Advanced Medical Solutions Grp PLC
12 May 2004


For Immediate Release                                    Wednesday 12th May 2004


         Advanced Medical Solutions Group plc ('AMS' or 'the Company')
              Announces collaboration with Nitto Medical for Japan


Winsford, UK: Advanced Medical Solutions, (AIM: AMS), the global woundcare
technology company, announces today that it has signed a collaboration agreement
with Nitto Medical Corporation, a division of Japan's Nitto Denko Group.

Under the terms of the agreement, Nitto Medical will undertake market evaluation
and regulatory approval of a number of AMS' woundcare products with the option
of entering into marketing and distribution agreements for these products in
Japan.

Established in 1918, Nitto Denko Group is a 453 billion Yen (£2.14 billion)
turnover Japanese materials technology company with three business sectors -
industrial products, electronic products and functional products. Within the
functional products sector, the Group has a range of healthcare products
including medical tapes and transdermal drug delivery patches.

Nitto Medical, a subsidiary formed in 1996, sells surgical tapes and woundcare
products through a sales team of 17 working with 50 distributors throughout
Japan.

Commenting on this announcement, Dr Don Evans, Chief Executive of AMS, stated:

'I am delighted that we have entered into a collaboration agreement with Nitto
Medical that gives us the opportunity to access the large Japanese woundcare
market with a strong and committed local player.

'We look forward to extending our collaboration beyond this initial agreement
both in terms of additional products in our current range and co-development
activity for new products.'

Mr. Toshiyuki Yamamoto, Director, Medical Device Division of Nitto Medical,
added:

'We are committed to establishing market leadership in niche markets by
focussing on selective areas and through intensive integration of technology.

'With its broad range of materials technology, AMS is an ideal partner for us in
woundcare.'

                                     -ENDS-


For further information, please contact:

Advanced Medical Solutions Group plc                   Tel : [phone]
Don Evans, Chief Executive
Mary Tavener, Finance Director
www.admedsol.com

Buchanan Communications                                Tel: [phone]
Mark Court, Mary-Jane Johnson


Notes to Editors:

Advanced Medical Solutions is a leading company in the development and
manufacture of products for the $15 billion global woundcare market.

Founded in 1991 and currently quoted on AIM, Advanced Medical Solutions is
focused on the design, development and manufacture of innovative and
technologically advanced products for woundcare and other medical applications.

In-house natural and synthetic polymer technology is used to provide advanced
wound dressings based on the moist healing principle. AMS's resources ensure a
unique position as a vertically integrated 'one stop shop' to provide all
categories of moist wound healing products. The Company has the capability to
move from product design and development through to production and delivery
ready for distribution into customer markets.

The acquisition of MedLogic in 2002 has brought AMS products and technology in
cyanoacrylate based tissue adhesives and sealants sold direct to hospitals or
through distributors.

AMS's technology and products currently serve the majority of the key global
markets with strategic partners including 3M, Novartis, Johnson & Johnson Inc,
Molnlycke Healthcare, Coloplast, Smith + Nephew and Beiersdorf.


                      This information is provided by RNS
            The company news service from the London Stock Exchange